To determine the structure and the mechanism of synthesis of mouse hepatitis virus mRNA, the map positions of the large RNase TI-resistant oligonucleotides of the seven mouse hepatitis virus strain A59 intracellular mRNA species were studied. We found that all but one of the oligonucleotides were mapped at the positions within each mRNA consistent with the nested-set, stairlike structure of mouse hepatitis virus mRNA (Lai et al., J. Virol. 39:823-834). However, one oligonucleotide, 10, was mapped near the 5' ends of every mRNA and virion genomic RNA. In other words, oligonucleotide 10 and, therefore, the sequences around the 5' ends of the mRNAs are not colinear with the genomic sequences. Because this oligonucleotide is present only once in the genomic RNA, this result indicates that oligonucleotide 10 is not transcribed from multiple sites on the genomic template, but rather represents a leader RNA sequence which is joined to the body sequences of the different mRNAs during mRNA transcription. This provides the most direct evidence thus far for the presence of leader sequences in the mRNAs of mouse hepatitis virus, which is a cytoplasmic virus. Several possible mechanisms of RNA synthesis are discussed.
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Mouse hepatitis virus, a member of the coronaviruses, contains a single-stranded and positive-sensed RNA of 5.4 x 106 molecular weight (7, 8, 12) . The virion RNA is transcribed into a genome-sized, negative-stranded RNA by a virus-coded RNA polymerase soon after infection (2, 6) . This negative-stranded RNA then serves as the template for the synthesis of seven mRNAs (4, 9, 10) . These mRNAs range from 2 to 20 kilobases in size and have a nested-set structure in which the sequences of every mRNA are completely included within the sequences of the next-larger mRNA, and all the mRNAs start from the 3' end of the genome (4) . UV light inactivation studies of the synthesis of the mRNAs suggested that each is synthesized independently rather than derived from the cleavage of a precursor RNA (3) . Each mRNA contains a cap structure at the 5' end (8) . Furthermore, these mRNAs also contain two unusual structural features. First, several contain unique RNase Tl-resistant oligonucleotides which are not found in the genome (4, 5, 9) . Second, the 5'-end sequences of these mRNAs share at least five nucleotides (5 The A59 strain of mouse hepatitis virus (MHV) was used throughout these experiments. To understand the mechanism of RNA synthesis by this virus, we examined the detailed mRNA structure by mapping the genomic locations of the large RNase T1-resistant oligonucleotides on every mRNA. This was achieved by "fingerprinting" the various size classes of 3'-end fragments derived from each mRNA according to the strategy published previously (4) . This ap-1028 NOTES proach would reveal whether all of the sequences in the MHV mRNAs were indeed colinear with the genomic RNA. For this purpose, the 32P-labeled RNA isolated from the MHVinfected L-2 cells was separated by electrophoresis on 1% agarose gels, and the seven mRNA species were eluted from the gel by published procedures (5) . The individual RNAs were heated at 100°C for 3 min to partially degrade the RNA and then were bound to and eluted from an oligodeoxythymidylate-cellulose column. The polyadenylate-containing RNA was collected and separated on a 10 to 25% sucrose gradient (4) . The RNAs of different sizes, which represent the RNA segments extending from the 3' end of the genome, were pooled and analyzed by fingerprinting of Tl-resistant oligonucleotides.
The oligonucleotides contained in mRNA no. 7 were separated into three groups according to their map positions on the RNA genome ( Fig. 1 ).
(A summary of the oligonucleotide map is presented below in Fig. 3 .) It is noteworthy that A 18S 2 E 4S oligonucleotides 10 and 19 were mapped in the 5' half of the mRNA. We could not obtain a finer map because of the small size of this RNA. Similar mapping studies were carried out for all of the mRNAs. (Some representative fingerprints are presented in Fig. 2 , and schematic maps are presented in Fig. 3 .) The oligonucleotides shared between mRNA no. 6 and 7 were mapped at the same corresponding locations. Furthermore, all of the oligonucleotides which are unique to mRNA no. 6 , but not present in mRNA no. 7, e.g., oligonucleotides 3, 17, 37, 39, and 63, were located at the 5' half of mRNA no. 6 (3). This result confirms our previous studies on the structure of MHV mRNA (4). However, a surprising finding emerged when the oligonucleotide map of mRNA no. 3 was examined. In this mRNA, essentially all of the oligonucleotides except one were mapped to their expected map positions according to the nested-set, stairlike structure of mRNAs (4 This result thus strongly indicated that oligonucleotide 10 represents a leader RNA segment which is joined to the body sequences of every mRNA. This provides the strongest evidence so far for the involvement of RNA rearrangement during the synthesis of MHV mRNA, which was suggested by our previous studies of the mRNA structure (4, 5) . Thus, there are three separate pieces of evidence, derived from the structural studies of mRNA, in support of RNA rearrangement during mRNA synthesis: (i) 5'-end sequences are identical for at least five nucleotides (5); (ii) several mRNAs contain an internal oligonucleotide (e.g., oligonucleotide 19a in mRNA no. 6 and oligonucleotide 3a in mRNA no. 5) not present in the genome (4, 5, 9) ; (iii) one oligonucleotide has been mapped near the 5' end and is not colinear with the genomic sequences. The RNA rearrangement involved in MHV mRNA synthesis has to be different from conventional RNA splicing, because MHV replicates exclusively in the cytoplasm (1, 13), and UV light inactivation studies suggest that MHV mRNA is not derived from a large precursor RNA (3). Several models are compatible with these results. First, the RNA polymerase could jump from the leader RNA region to the body sequences of mRNA. This could be facilitated by the presumable secondary structure of the RNA, bringing these two regions together. Second, the leader RNA could be synthesized independently and then used as a primer for mRNA synthesis. Third. the leader RNA could be synthesized independently and added to the mRNA after completion of its synthesis. Experiments are in progress to determine which model is correct.
The leader RNA sequences of MHV probably consist of, at least, 5'-cap-containing oligonucleotide 82 (5 nucleotides) and oligonucleotide 10 (23 nucleotides) (5) . Thus, the minimum length of the MHV leader RNA is 28 nucleotides. As we discussed previously (5), part of oligonucleotide 19 (23 nucleotides) could also be included in this leader region, as this oligonucleotide might represent the junction region between the leader and body sequences for the following reasons: it was mapped close to the 5' end of the mRNAs; it is not present in some of the mRNAs, but oligonucleotides of related sequences are present in its place in other mRNAs (e.g., oligonucleotide 19a in mRNA no. 6) (5, 9). Thus, the MHV leader RNA sequences could be considerably longer.
It should be pointed out that in previous oligonucleotide mapping of genomic RNA (4), we mapped oligonucleotides 10 and 19 to the 3' end of the MHV genome. This conclusion was not consistent with all of the fingerprints, as these two oligonucleotides were detected only in the 3' RNA fragments of roughly 18S and fulllength genomic RNA but not in 3' RNA fragments of intermediate size (4) . In that report, we attributed this contradiction to artifacts of fingerprinting. However, in light of the results reported here, it is likely that the presence of oligonucleotides 10 and 19 in the small fragments of genomic RNA isolated from purified virion was probably due to the presence of the small amount of mRNA no. 7 in the virion. To map these oligonucleotides more precisely on the genome-sized RNA, we performed (Fig. 4) 
